We thank the National Cancer Institute for the following information. What is coronavirus, or COVID-19? Coronaviruses are a large family of viruses that are common in people and many different species of animals. Governments across the world are belatedly responding to an outbreak of respiratory disease caused by a novel (new) coronavirus that is now…
Details
Transgene, a biotechnology company based in France, has successfully given a new immunotherapeutic drug to a first person in a Phase 1/2a clinical trial at St. James Hospital, Leeds. The trial tests the drug TG6002 on colorectal cancer patients with inoperable liver metastasis. At the Leeds trial, the new drug was delivered directly into the…
Details
Chemotherapy has been used extensively in the treatment of cancer for the past seventy years. It involves the use of toxic chemicals that kill rapidly dividing cells that build into a cancerous tumour. Unfortunately, classic chemotherapy not only destroys cancer cells but also healthy cells and can weaken or even destroy the patient’s immune system.…
Details
Illustration: Massachusetts General Hospital As we noted in our CAR T Cell Therapy blog, ( 6 November, 2019), there has been a surge in the understanding of how to activate the body’s immune system to combat cancer. The development and use of modified cells, known as chimeric antigen receptor CAR T Cells which have the…
Details